Changes of the sympathoadrenal and adrenocortical activity in the course of cardiac hypertrophy and heart failure.
D000109:Acetylcholine / Q000032:analysis; D000311:Adrenal Glands / Q000503:physiopathology*; D000313:Adrenal Medulla / Q000503:physiopathology*; D000818:Animals; D001022:Aortic Valve Insufficiency / Q000503:physiopathology*; D001205:Ascorbic Acid / Q000032:analysis; D006332:Cardiomegaly / Q000503:physiopathology*; D002395:Catecholamines / Q000032:analysis / Q000097:blood; D003345:Corticosterone / Q000032:analysis / Q000097:blood; D006321:Heart / Q000503:physiopathology*; D006333:Heart Failure / Q000503:physiopathology*; D006973:Hypertension / Q000209:etiology; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D009929:Organ Size; D011817:Rabbits
D002395:Catecholamines; D000109:Acetylcholine; D001205:Ascorbic Acid; D003345:Corticosterone; D009638:Norepinephrine